Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), March 2025 The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis. Suitable patients include those with recent syphilis or other STI diagnoses, periods of increased risk, or who wish to protect...
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), & Blood Borne Viruses and Sexually Transmitted Infections Standing Committee (BBVSS), 2023 The Australian STI Management Guidelines were updated between 2020-2022 by a multidisciplinary group of clinical and non-clinical experts. While all sections have been updated, some have had major changes. The key changes...
Guardian Australia, Wed 17 Mar 2021 03.30 AEDT GPs have been urged not to test gay men for one of the most prevalent sexually transmitted infections unless they have symptoms, with new research from the Melbourne Sexual Health Centre warning that treating asymptomatic men is accelerating its resistance to antibiotics. Many general practitioners have begun testing for Mycoplasma Genitalium as part...
Australian Federation of AIDS Organisations (AFAO), 26 June 2018 There has long been concern globally about the potential emergence of drug resistant STIs. In response, the World Health Organisation released new treatment guidelines for three common STIs – chlamydia, gonorrhoea and syphilis – in 2016. At present, strains resistant to first line treatment of syphilis and chlamydia are not common...
SMH, 13/02/2018 Cases of a strain of gonorrhoea impervious to an antibiotic have almost tripled in six months, the latest report from the National Alert System for Critical Antimicrobial Resistance (CARAlert) reveals. The result was a “warning shot across the bow” for doctors and public health officials fighting antibiotic resistance, CARAlert’s senior medical adviser said. Read more...
New Zealand Family Planning Some strains of the bacterium that cause gonorrhoea are now resistant to all available antibiotics. With no new drugs on the near horizon, the disease is in desperate need of a vaccine. Our research, published in the Lancet medical journal this week, shows that protection against gonorrhoea could come from an unexpected source – a vaccine against meningococcal...